Related Experiment Video
Updated: Aug 23, 2025

10:12
Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
Published on: December 16, 2021
2.8K
Agonist (P1) Antibody Converts Stem Cells into Migrating Beta-Like Cells in Pancreatic Islets
Eun Ji Lee1, Seung-Ho Baek2, Chi Hun Song1
1Department of Biological Sciences and Biotechnology, Hannam University, Daejeon 34054, Republic of Korea.
Journal of Microbiology and Biotechnology
|November 4, 2022
Summary
Researchers identified P1 antibody, which directs stem cells to pancreatic islets and differentiates them into beta-like cells, aiding tissue regeneration for degenerative diseases.
Area of Science:
- Stem cell biology
- Immunology
- Regenerative medicine
Background:
- Tissue regeneration is crucial for treating degenerative diseases but remains a significant challenge.
- Previous work demonstrated antibody-induced stem cell differentiation and tissue-specific migration.
Purpose of the Study:
- To identify novel antibodies capable of inducing stem cell differentiation and targeted migration.
- To investigate the potential of P1 antibody in regenerating pancreatic beta-like cells.
Main Methods:
- Selection of agonist antibodies using an in vivo system.
- Differentiation of human CD34+ hematopoietic stem cells and mouse bone marrow cells.
- Assessment of cell migration to pancreatic islets and differentiation into beta-like cells.
Main Results:
- P1 antibody successfully induced migration of stem cells to pancreatic islets.
- Purified P1 antibody differentiated human stem cells into functional beta-like cells.
- Stem cells bound to P1 antibody selectively migrated to mouse pancreatic islets, guided by periostin expression.
Conclusions:
- The in vivo selection system effectively identifies antibodies for stem cell differentiation and tissue-specific homing.
- P1 antibody shows promise for regenerating pancreatic islets and treating diabetes.
- This approach offers a novel strategy for tissue regeneration and remodeling in degenerative diseases.

